Instrument Inactif

Communiqués Ranbaxy Laboratories Limited

Actions

RANB

INE015A01028

Produits pharmaceutiques

Cours en clôture NSE India S.E.
- ^INR	-

17/07/14	Novartis : confirme l'objectif de croissance de ses ventes	RE
17/07/14	Novartis : confirme l'objectif de croissance du C.A. annuel	RE

Communiqués

04/03/15	Ranbaxy Laboratories : & APICON BREAK GUINNESS WORLD RECORD™	PU
28/01/15	Ranbaxy Laboratories : Q3FY 2015 Sales Rs.25,876Mn. YTD Dec’14 Sales Rs.81,778Mn	PU
06/12/14	Ranbaxy Laboratories : launches Red Heart Initiative to Raise Awareness on Women Heart Health	PU
01/12/14	Ranbaxy Laboratories : launches India’s first biosimilar of Infliximab drug, Infimab™	PU
29/07/14	Ranbaxy Laboratories : Q1 FY 2015 (Apr’14-Jun’14) Sales Rs.23.7 Bn	PU
25/07/14	Ranbaxy Laboratories : and Cipher Announce Signing of Licensing Agreement for Isotretinoin	PU
27/06/14	Ranbaxy Laboratories : OHM Laboratories To Launch Valsartan Tablets	PU
09/05/14	Ranbaxy Laboratories : January – March 2014 Sales at Rs.24.4 Bn	PU
07/04/14	Ranbaxy Laboratories : Communication to the Stock Exchange	PU
07/04/14	Ranbaxy Laboratories : Sun Pharma to acquire Ranbaxy in a US$4 billion landmark transaction	PU
22/03/14	Ranbaxy Laboratories : Declares Research Awards 2012 “Honours Five Outstanding Scientists & Five Young Science Scholars”	PU
21/03/14	Ranbaxy Laboratories : DSIN, Ranbaxy & RSC organize Symposium on “Overcoming the Bottlenecks in Drug Discovery and Development”	PU
18/03/14	Ranbaxy Laboratories : Communication to the Stock Exchange	PU
21/02/14	Ranbaxy Laboratories Limited : Ranbaxy & APICON Break the Guinness World Records™	PU
18/02/14	Ranbaxy Laboratories Limited : APICON & Ranbaxy Attempt to break Guinness World Records™	PU
05/02/14	Ranbaxy Laboratories Limited : Ranbaxy Q4 FY14 Sales Rs.28.6 Bn. YTD Dec 2013 Sales Rs.106.0 Bn	PU
24/01/14	Ranbaxy Laboratories Limited : Press Statement	PU
13/01/14	Ranbaxy Laboratories Limited : Press Statement	PU
09/01/14	Ranbaxy Laboratories Limited : Ranbaxy and EPIRUS Announce Signing of Licensing Agreement for Biosimilar Product	PU
08/01/14	Ranbaxy Laboratories Limited : RANBAXY RECEIVES APPROVAL TO MARKET RAN™-DONEPEZIL IN CANADA	PU
09/12/13	Ranbaxy Laboratories Limited : Anil “Jumbo” Kumble scores another wicket – against cardiovascular disease – at CSI, Bangalore	PU
20/11/13	Ranbaxy Laboratories Limited : RANBAXY COMPLETES 20 YEARS IN UKRAINE	PU
29/10/13	Ranbaxy Laboratories Limited : Ranbaxy Q3 CY 2013 Sales Rs.27.5 Bn. YTD Sep 2013 Sales Rs.77.5 Bn	PU
21/10/13	Ranbaxy Laboratories Limited : Ranbaxy receives CDSCO approval to market Synriam™ in India for treatment of malaria caused by Plasmodium vivax parasite	PU
20/09/13	Ranbaxy Laboratories Limited : RANBAXY RECEIVES PARAGRAPH IV CERTIFICATION	PU